South Korea has signed a contract to purchase 10 million doses of the country’s first coronavirus vaccine developed by SK Bioscience as the vaccine candidate codenamed GBP510 has met pre-purchase conditions of regulatory approval of Phase 3 clinical trials, authorities said on Monday.

[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]